US 10487105
Trinucleotide MRNA cap analogs
granted A61KA61K31/7125A61K45/06
Quick answer
US patent 10487105 (Trinucleotide MRNA cap analogs) held by ARCTURUS THERAPEUTICS, INC. expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7125, A61K45/06